Savior Lifetec Corporation

NT$18.40As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4167Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (1.61%)
Div yield 4.09%
ROE 25.70%
Biotechnology
Beta (5Y) 0.09
PE TTM 5.939
TSR TTM 19.65%
Mkt cap NT$6.101B
ROIC 5.18%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$23
23.87%
(42.90%)
Hold 7|8|9|4|12
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.18
0.19
0.21
0.22
3.91%
17.53%
15.72%
24.80%
RevenueNT$M
258.6
259.1
264.6
261.7
(5.36%)
(3.26%)
0.44%
0.24%
Peers (US$184.3M)
Cap (US$)
PE
192.3M
—
183.9M
—
Capital
TTM
5Y
10Y
Leveragex
0.685
(0.366)
(0.319)
EBIT/Intx
1.874
0.262
0.279
Own earn%
(100.07)
(194.63)
(151.08)
Sh yield%
36.53
36.19
35.20
Owners
Insiders/Inst%
5.11
71.11
Short interest%
2.82
SBC / revenue%
3.73
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
36–44
$1 testx
—
Incr. ROIC%
3